Biotech IPOs City Therapeutics and Iambic headline this week's pricings.
Context
What happened: Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint.
Key numbers: $200 million raised; $1.0 billion market cap.
Why it matters: City Therapeutics is a Phase 1 biotech, and it headlined the week's pricings alongside Iambic.
Coverage: 3 outlets in 24h